| Preoperative management |
|
|
| 1. Panretinal photocoagulation |
% |
n |
| Yes |
85.8% |
91 |
| No |
14.2% |
15 |
| 2. Bevacizumab (1.25mg) |
|
|
| Yes |
23.6% |
25 |
| No |
76.4% |
81 |
| Intraoperative management |
|
|
| 1. Vitrectomy gauge |
|
|
| i. 23G |
91.5% |
97 |
| ii. 20G |
8.5% |
9 |
| 2. Combined phaocemulsification and vitrectomy |
34.9% |
37 |
| 3. Staining Adjuvant |
|
|
| i. None |
63.6% |
63 |
| ii. Triamcinolone |
29.2% |
31 |
| iii. Trypan Blue |
10.4% |
11 |
| iv. Triamcinolone and Trypan Blue |
0.9% |
1 |
| 4. Endotamponade |
|
|
| i. None |
52.8% |
56 |
| ii. SF6 |
9.4% |
10 |
| iii. C2F6 |
2.8% |
3 |
| iv. C3F8 |
0.9% |
1 |
| v. Silicone oil |
28.3% |
30 |
| vi. Air |
5.7% |
6 |
|
